David Brocklehurst
David Brocklehurst, head of Oncology UK, AstraZeneca UK Limited
HSJ PartnersBetter, faster, stronger: Incentivising capacity for NHS cancer care
By prioritising a new approach to incentives, policymakers can help create system capacity in cancer services, especially at a time when organisational reform and major financial investment are unlikely, writes David Brocklehurst